• HOME
  • LOGIN
  • JOIN

사이트 메뉴

  • 회사소개
    • ABOUT US
    • ABOUT US(영문)
    • CEO 인사말
    • 연혁
    • 조직도
  • 제품소개
    • HT-3000
    • Hydrosun(하이드로선)
      1. - 의료용
      2. - 개인용
    • 신아바이오 공기살균기
      1. - 제품소개
      2. - 모델별 소개
      3. - 제품 인증서/시험성적서
    • 셀시우스TCS
  • 홍보센터
    • 공지사항/주요소식
    • 세미나/학회정보
  • 회원자료실
    • 문헌정보
    • Clinical Study
    • 뉴스레터
    • 마케팅자료실
  • CONTACT US
    • 구입/서비스문의
    • 온열치료 FAQ
    • 협력사
    • 오시는 길

회원자료실

  • 문헌정보
  • Clinical Study
  • 뉴스레터
  • 마케팅자료실
[hydrosun] Serial locally applied water-filtered infrared a radiation in axial spondyloarthritis – a randomized controlled trial

관리자 | 2021.06.25 | 조회 1

[HT3000] Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer

관리자 | 2021.06.25 | 조회 1

[HT3000] Effects of Fever-Range Hyperthermia on T Cell-Mediated Immunity: Possible Combination of Hyperthermia and T Cell-Based Cancer Immunotherapy

관리자 | 2021.06.25 | 조회 1

[HT3000] Temperature Matters! And Why it Should Matter to Tumor Immunologists.

관리자 | 2021.06.25 | 조회 1

[HT3000] Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery.

관리자 | 2021.06.25 | 조회 1

[HT3000] Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia, and enhances efficacy of radiotherapy in murine tumor models.

관리자 | 2021.06.25 | 조회 1

[HT3000] Fever-Range Whole-body Thermotherapy Combined With Oxaliplatin: A Curative Regimen in a Preclinical Breast Cancer Model.

관리자 | 2021.06.25 | 조회 1

[HT3000] Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy

관리자 | 2021.06.25 | 조회 1

[HT3000] Near complete remission of pulmonary metastases in triple negative breast cancer (TNBC) using low-dose immune checkpoint (IC) inhibitors with high dose (HD) interleukin-2 (IL-2) and fever ran

관리자 | 2021.06.25 | 조회 1

[HT3000] Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers – a retrospectiv

관리자 | 2021.06.25 | 조회 1

[ 1 ] 2

바이오메디신 주식회사

  • 이용약관
  • 개인정보취급방침
  • 이메일주소무단수집거부

주소 : (우:15807) 경기도 군포시 엘에스로 172, 708호 (금정동, 한림휴먼타워) | 회사명 : 바이오메디신 주식회사 | 대표이사 : 강상만 | 사업자등록번호 : 214-88-22523
Email : info@biomedisyn.kr | Tel : 031-383-3144 | Fax : 031-383-3166

Copyright ⓒ 바이오메디신 주식회사 All rights reserved. Designed & Programmed by WHOIS